Par Drugs and Chemicals Limited

PAR

INE04LG01015

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:40:31 2024-05-21 am EDT			5-day change	1st Jan Change
252.8 ^INR	-3.44%		+2.45%	+17.22%

May. 09	Par Drugs and Chemicals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
Feb. 16	Par Drugs and Chemicals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Par Drugs and Chemicals Limited Reports Earnings Results for the Half Year Ended September 30, 2019

November 10, 2019

Par Drugs and Chemicals Limited announced earnings results for the half year ended September 30, 2019. For the half year, the company announced sales was INR 291.114 million compared to INR 248.616 million a year ago. Net income was INR 15.886 million compared to INR 20.934 million a year ago. Basic earnings per share was INR 2.58 compared to INR 7.75 a year ago.

Latest news about Par Drugs and Chemicals Limited

Par Drugs and Chemicals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 09	CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 16	CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-28	CI
Par Drugs and Chemicals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-03	CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-04-27	CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-10	CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-09	CI
Par Drugs and Chemicals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-07-28	CI
1,232,000 Equity Shares of Par Drugs and Chemicals Limited are subject to a Lock-Up Agreement Ending on 16-MAY-2022.	22-05-15	CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-05-07	CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-07	CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-09	CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Full Year Ended March 31, 2021	21-08-04	CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	20-10-29	CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Full Year Ended March 31, 2020	20-06-01	CI
Par Drugs and Chemicals Limited Recommends Final Dividend for the Financial Year 2019-20	20-06-01	CI
4,480,318 Equity Shares of Par Drugs and Chemicals Limited are subject to a Lock-Up Agreement Ending on 16-MAY-2020.	20-05-15	CI
Par Drugs and Chemicals Limited Reports Earnings Results for the Half Year Ended September 30, 2019	19-11-10	CI
Par Drugs and Chemicals Limited has completed an IPO in the amount of INR 85.272 million.	19-05-13	CI
Par Drugs and Chemicals Limited has filed an IPO.	19-03-29	CI

Chart Par Drugs and Chemicals Limited

Duration

Period

More charts

Company Profile

Par Drugs and Chemicals Limited is an India-based company engaged in manufacturing of active pharma ingredients (APIs) and fine chemicals for the domestic market as well as for exports to international markets. The Company manufactures a diverse range of antacid molecules. The Companyâs products include magnesium hydroxide, magnesium trisilicate, magnesium carbonate, light magnesium oxide, magnesium oxide heavy, magnesium oxide USP, dried aluminum hydroxide gel, magaldrate, magnesium aluminum silicate hydrated, alma gate, hydrotalcite, aluminum hydroxide magnesium carbonate co-dried gel, aluminum-magnesium silicate BP, sodium aluminum silicate, precipitated silica, magnesium silicate, amorphous, colloidal silicon dioxide, and sucralfate USP. The Company owns and operates its manufacturing facilities at Bhavnagar in Gujarat. It has over four manufacturing blocks at Bhavnagar, which are for different products, having a capacity of approximately 9,700 metric tons per annum.

Sector

Pharmaceuticals

Calendar

2024-07-31 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PAR DRUGS AND CHEMICALS LIMITED	+17.22%	38.55M
ELI LILLY AND COMPANY	+38.00%	705B
NOVO NORDISK A/S	+32.82%	583B
JOHNSON & JOHNSON	-3.69%	364B
MERCK & CO., INC.	+20.10%	332B
ABBVIE INC.	+4.91%	291B
ASTRAZENECA PLC	+16.64%	238B
ROCHE HOLDING AG	-4.13%	210B
NOVARTIS AG	+10.63%	209B
AMGEN INC.	+8.74%	169B

Other Pharmaceuticals